Michael Bonner

Michael Bonner is a declared insider of Cumberland Pharmaceuticals Inc (finance chief), with filings sourced from SEC (Form 4). We count 20 filings; the first trade dates from 6 April 2016 and the latest from 17 May 2021.

Purchases make up the whole of the open-market record (9 purchases, €22k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 10 share grants.

The median purchase comes to €1,854. 2 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 11 June 2021, the filings show a transaction worth €17k in Cumberland Pharmaceuticals Inc. The clock since the last published purchase (31 August 2018) now reads 2,992 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.